ECNS - ETF AI Analysis
Top Page
iShares MSCI China Small-Cap ETF (ECNS)
ECNS, the iShares MSCI China Small-Cap ETF, reflects a mixed overall quality, combining some solid growth stories with several challenged companies. Strong contributors like Minth Group and Atour Lifestyle Holdings support the fund’s rating through healthy financial performance and generally positive price trends, while weaker holdings such as GCL-Poly Energy Holdings and Zai Lab, which face profitability and cash flow issues along with bearish trading signals, weigh on the outcome. The main risk is the ETF’s focus on smaller Chinese companies, where financial instability and negative momentum in several holdings can make returns more volatile.
ECNS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 56.30M
- Region
- Asia-Pacific
- Expense Ratio
- 0.59%
- Beta
- 0.83
- Issuer
- iShares
- Inception Date
- Sep 28, 2010
- Dividend Yield
- 7.46%
- Asset Class
- Equity
- Index Tracked
- MSCI China Small Cap
ECNS Summary
ECNS is the iShares MSCI China Small-Cap ETF, which follows the MSCI China Small Cap index. It invests in many smaller Chinese companies across sectors like health care, technology, and industrials. Some of its holdings include Kingdee International Software Group and Zai Lab, which are involved in software and biotech. Investors might consider ECNS if they want growth potential from up-and-coming Chinese businesses and broader diversification beyond large, well-known firms. However, small-cap stocks in China can be very volatile, so the ETF’s value can rise and fall sharply with changes in the Chinese market.
How much will it cost me?
This ETF has an expense ratio of 0.59%, which means you’ll pay about $5.90 per year for every $1,000 invested. That’s higher than the average low-cost index ETF because it focuses on a more specialized, harder-to-access area of the market: Chinese small-cap stocks.
What would affect this ETF?
This ETF could benefit if China’s economy strengthens, government support for technology and health care continues, and smaller companies gain from innovation and rising consumer spending, helping its many tech, health care, and industrial holdings. On the negative side, it is highly exposed to China-specific risks such as regulatory crackdowns, slower economic growth, and geopolitical tensions, and small-cap stocks can be more volatile and sensitive to changes in investor confidence and global interest rates.
ECNS Top 10 Holdings
ECNS is a pure play on Chinese small caps, with most of its firepower in tech, health care, and communication services. TCL Electronics and JOYY have been quietly rising, helping to prop up returns, while Zai Lab’s mixed pattern and Kingdee’s losing steam keep the ride bumpy. Consumer and lifestyle names like Atour are lagging, and media player China Ruyi plus Meitu are dragging the fund with weaker trends. With all holdings rooted in China, performance is tightly tied to the country’s domestic growth and sentiment.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 HK:0268 | Kingdee International Software Group Co | 2.26% | $1.26M | HKD 29.85B | -41.19% | 50Neutral |
 HK:9688 | Zai Lab Ltd | 1.74% | $969.60K | HKD 21.69B | -14.77% | 42Neutral |
 HK:0257 | China Everbright | 1.58% | $879.51K | HKD 29.46B | -2.54% | 66Neutral |
 ATAT | Atour Lifestyle Holdings | 1.52% | $842.82K | $4.47B | -14.56% | 75Outperform |
 HK:0425 | Minth Group | 1.43% | $792.20K | HKD 25.33B | -38.37% | 71Outperform |
 HK:1070 | TCL Electronics Holdings | 1.41% | $783.92K | HKD 38.32B | 63.44% | 66Neutral |
 JOYY | JOYY | 1.39% | $774.85K | $3.93B | 33.62% | 60Neutral |
 HK:0136 | China Ruyi Holdings Limited | 1.36% | $753.12K | HKD 20.60B | -55.05% | 51Neutral |
 HK:0189 | Dongyue Group Limited | 1.26% | $702.53K | HKD 16.00B | -5.01% | 62Neutral |
 HK:3800 | GCL Technology Holdings Limited | 1.24% | $686.71K | HKD 19.43B | -57.61% | 38Underperform |
ECNS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ECNS, the sentiment is Negative. The current price of 25.44 is below the 20-day moving average (MA) of 26.69, below the 50-day MA of 27.65, and below the 200-day MA of 30.84, indicating a bearish trend. The MACD of -0.53 indicates Positive momentum. The RSI at 27.84 is Positive, neither overbought nor oversold. The STOCH value of 8.66 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ECNS.
ECNS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| ECNS | $25.44 | $28.00(10.06% Upside) | $56.30M | 0.59% | 55Neutral |
 MCHI | $49.07 | $69.82(42.29% Upside) | $5.49B | 0.59% | 58Neutral |
 FXI | $33.08 | $47.06(42.26% Upside) | $3.75B | 0.74% | 73Outperform |
 PGJ | $20.82 | $30.51(46.57% Upside) | $76.42M | 0.70% | 67Neutral |
 FCA | $23.74 | $34.56(45.59% Upside) | $27.18M | 0.80% | 68Neutral |
 MJSC | $57.68 | ― | $21.92M | 1.01% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ECNS | iShares MSCI China Small-Cap ETF | 25.44 | -8.97 | -26.07% | |
| MCHI | iShares MSCI China ETF | 49.07 | -13.30 | -21.32% | |
| FXI | iShares China Large-Cap ETF | 33.08 | -6.03 | -15.41% | |
| PGJ | Invesco Golden Dragon China Etf | 20.82 | -10.57 | -33.68% | |
| FCA | First Trust China AlphaDEX Fund | 23.74 | -3.76 | -13.68% | |
| MJSC | MUFG Japan Small Cap Active ETF | 57.68 | 8.79 | 17.98% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.